Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Addressing body image and weight can help improve female sexual dysfunction.

Araliadiol may promote hair growth like minoxidil without being toxic.

Some medications can help increase sexual desire and function in women.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Treating hematospermia can improve sexual function and reduce anxiety.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Effective pain management in multiple sclerosis requires individualized treatment strategies.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Treatments for urinary symptoms often cause ejaculatory problems.

Hidradenitis suppurativa negatively affects patients' sexual lives and relationships, highlighting the need for better support and communication about sexual health.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The questionnaire is valid and reliable but needs more testing for future predictions.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.